首页 磁力链接怎么用

Lecturio - Pharmacology

文件类型 收录时间 最后活跃 资源热度 文件大小 文件数量
视频 2019-9-11 20:51 2024-12-24 15:10 119 5.43 GB 186
磁力链接
magnet:?xt=urn:btih:6a363264abcc5e0159e968cb8ec1b1ae7460caf6
迅雷链接
thunder://QUFtYWduZXQ6P3h0PXVybjpidGloOjZhMzYzMjY0YWJjYzVlMDE1OWU5NjhjYjhlYzFiMWFlNzQ2MGNhZjZaWg==
二维码链接
Lecturio - Pharmacology的二维码
种子下载(838888不存储任何种子文件)
种子下载线路1(迅雷)--推荐
种子下载线路2(比特彗星)
种子下载线路3(torcache)
3条线路均为国内外知名下载网站种子链接，内容跟本站无关！
相关链接

Lecturio - Pharmacology

文件列表
  1. 01. Antimicrobial Pharmacology/01.01 Overview – Cell Wall Synthesis Inhibitors (Antibiotics).mp46.9MB
  2. 01. Antimicrobial Pharmacology/01.02 Penicillins – Cell Wall Synthesis Inhibitors (Antibiotics).mp430.16MB
  3. 01. Antimicrobial Pharmacology/01.03 Cephalosporins – Cell Wall Synthesis Inhibitors (Antibiotics).mp420.16MB
  4. 01. Antimicrobial Pharmacology/01.04 Carbapenems – Cell Wall Synthesis Inhibitors (Antibiotics).mp46.95MB
  5. 01. Antimicrobial Pharmacology/01.05 Vancomycin, Bacitracin and Daptomycin – Cell Wall Synthesis Inhibitors (Antibiotics).mp419.69MB
  6. 01. Antimicrobial Pharmacology/01.06 Overview – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp433.48MB
  7. 01. Antimicrobial Pharmacology/01.07 Linezolid, Streptogramins and Chloramphenicol – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp430.75MB
  8. 01. Antimicrobial Pharmacology/01.08 Macrolides and Ketolides – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp424.42MB
  9. 01. Antimicrobial Pharmacology/01.09 Tetracyclines – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp423.32MB
  10. 01. Antimicrobial Pharmacology/01.10 Aminoglycosides – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp436.91MB
  11. 01. Antimicrobial Pharmacology/01.11 Quiz Questions and Case Studies – Antibacterial Agents (Antibiotics).mp447.83MB
  12. 01. Antimicrobial Pharmacology/02.01 Overview – Antimetabolites.mp45.57MB
  13. 01. Antimicrobial Pharmacology/02.02 Sulfonamides, Trimethoprim and Fluoroquinolones – Antimetabolites.mp456.7MB
  14. 01. Antimicrobial Pharmacology/02.03 Case Studies – Antimetabolites.mp422.13MB
  15. 01. Antimicrobial Pharmacology/02.04 Overview – Antimycobacterial Agents.mp46.48MB
  16. 01. Antimicrobial Pharmacology/02.05 Antituberculosis Drugs – Antimycobacterial Agents.mp441.65MB
  17. 01. Antimicrobial Pharmacology/02.06 Treatment Regimens for Mycobacterium Tuberculosis, Leprosy and Other Infections – Antimycobacterial Agents.mp424.91MB
  18. 01. Antimicrobial Pharmacology/02.07 Case Studies – Antimycobacterial Agents.mp438.87MB
  19. 01. Antimicrobial Pharmacology/03.01 Overview – Antifungals.mp44.88MB
  20. 01. Antimicrobial Pharmacology/03.02 Azoles – Antifungals.mp430.32MB
  21. 01. Antimicrobial Pharmacology/03.03 Polyenes – Antifungals.mp430.99MB
  22. 01. Antimicrobial Pharmacology/03.04 Flucytosine (5-Fluorocytosine5-FU) – Antifungals.mp410.02MB
  23. 01. Antimicrobial Pharmacology/03.05 Echinocandins and Squalene Epoxidase Inhibitor (Terbinafine) – Antifungals.mp413.45MB
  24. 01. Antimicrobial Pharmacology/03.06 Questions – Antifungals.mp418.86MB
  25. 01. Antimicrobial Pharmacology/04.01 Overview – Antiviral Drugs.mp416.95MB
  26. 01. Antimicrobial Pharmacology/04.02 Anti-HIV Agents Fusion Inhibitors – Antiviral Drugs.mp49.62MB
  27. 01. Antimicrobial Pharmacology/04.03 Anti-HIV Agents Nucleoside Reverse Transcriptase Inhibitors (NRTI) – Antiviral Drugs.mp457.3MB
  28. 01. Antimicrobial Pharmacology/04.04 Anti-HIV Agents Reverse Transcriptase Inhibitors (NNRTI) – Antiviral Drugs.mp431.61MB
  29. 01. Antimicrobial Pharmacology/04.05 Anti-HIV Agents Integrase Strand Transfer Inhibitors – Antiviral Drugs.mp415.16MB
  30. 01. Antimicrobial Pharmacology/04.06 Anti-HIV Agents Protease Inhibitors – Antiviral Drugs.mp449.02MB
  31. 01. Antimicrobial Pharmacology/04.07 Anti-HIV Agents CCR5 Antagonist – Antiviral Drugs.mp414.46MB
  32. 01. Antimicrobial Pharmacology/04.08 Questions about Anti-HIV Agents – Antiviral Drugs.mp413.84MB
  33. 01. Antimicrobial Pharmacology/04.09 Case Studies about Anti-HIV Agents – Antiviral Drugs.mp415.78MB
  34. 01. Antimicrobial Pharmacology/04.10 Anti-Herpes Agents Thymidine Kinase Agents – Antiviral Drugs.mp435.04MB
  35. 01. Antimicrobial Pharmacology/04.11 Anti-Herpes Agents RNA Polymerase Inhibitors and Other Drugs – Antiviral Drugs.mp423.04MB
  36. 01. Antimicrobial Pharmacology/04.12 Influenza Treatment – Antiviral Drugs.mp415.35MB
  37. 01. Antimicrobial Pharmacology/04.13 Hepatitis Treatment – Antiviral Drugs.mp444.01MB
  38. 01. Antimicrobial Pharmacology/04.14 Overview – Antiviral Agents and Treatment of CMV Retinitis – Antiviral Drugs.mp411.88MB
  39. 01. Antimicrobial Pharmacology/04.15 Case Study – Antiviral Drugs.mp441.6MB
  40. 01. Antimicrobial Pharmacology/05.01 Antimalarial Drugs – Antiprotozoal Agents.mp488.71MB
  41. 01. Antimicrobial Pharmacology/05.02 Amebicides – Antiprotozoal Agents.mp458.22MB
  42. 01. Antimicrobial Pharmacology/05.03 Nematicides – Antihelmintic Drugs.mp436.54MB
  43. 01. Antimicrobial Pharmacology/05.04 Trematocides (Praziquantel) and Cestodicides (Niclosamide) – Antihelmintic Drugs.mp415.42MB
  44. 01. Antimicrobial Pharmacology/05.05 Questions – Antiprotozoal and Antihelmintic Drugs.mp420.58MB
  45. 02. Pharmacokinetics and Pharmacodynamics/01.01 Introduction to Kinetics Pharmacokinetics (PK).mp432.04MB
  46. 02. Pharmacokinetics and Pharmacodynamics/01.02 Hydrophilic vs. Hydrophobic – Absorption and Distribution Pharmacokinetics (PK).mp427.02MB
  47. 02. Pharmacokinetics and Pharmacodynamics/01.03 pKa and Drug Solubility – Absorption and Distribution Pharmacokinetics (PK).mp436.57MB
  48. 02. Pharmacokinetics and Pharmacodynamics/01.04 Drug Distribution – Absorption and Distribution Pharmacokinetics (PK).mp436.55MB
  49. 02. Pharmacokinetics and Pharmacodynamics/01.05 Phases of Drug Development – Absorption and Distribution Pharmacokinetics (PK).mp438.58MB
  50. 02. Pharmacokinetics and Pharmacodynamics/02.01 Drug Metabolism – Biotransformation Pharmacokinetics (PK).mp449.38MB
  51. 02. Pharmacokinetics and Pharmacodynamics/02.02 Factors Affecting Drug Metabolism – Biotransformation Pharmacokinetics (PK).mp4108.04MB
  52. 02. Pharmacokinetics and Pharmacodynamics/03.01 Introduction and Definitions of Pharmacodynamics – Pharmacodynamics.mp416.09MB
  53. 02. Pharmacokinetics and Pharmacodynamics/03.02 Drug Receptors and Effectors – Pharmacodynamics.mp417.01MB
  54. 02. Pharmacokinetics and Pharmacodynamics/03.03 Upregulation and Downregulation – Pharmacodynamics.mp45.39MB
  55. 02. Pharmacokinetics and Pharmacodynamics/03.04 Dose-Response, Binding, Quantal, Toxicity & Potency Curves – Pharmacodynamics.mp472.49MB
  56. 02. Pharmacokinetics and Pharmacodynamics/04.01 Introduction esp. Types of Eliminations – Elimination Kinetics.mp422.54MB
  57. 02. Pharmacokinetics and Pharmacodynamics/04.02 First Pass Metabolism – Elimination Kinetics.mp413.43MB
  58. 02. Pharmacokinetics and Pharmacodynamics/04.03 Bioavailability incl. Case Study – Elimination Kinetics.mp415.1MB
  59. 02. Pharmacokinetics and Pharmacodynamics/04.04 Dosage Calculation Maintenance Dose and Loading Dose – Elimination Kinetics.mp435.64MB
  60. 02. Pharmacokinetics and Pharmacodynamics/04.05 Intravenous vs. Oral Medications – Elimination Kinetics.mp48.71MB
  61. 02. Pharmacokinetics and Pharmacodynamics/04.06 Renal Clearance – Elimination Kinetics.mp432.69MB
  62. 03. Inflammation Pharmacology/01. Pharmacology of Inflammation.mp447.98MB
  63. 03. Inflammation Pharmacology/02. Acetylsalicylic Acid (ASA).mp431.37MB
  64. 03. Inflammation Pharmacology/03. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).mp420.6MB
  65. 03. Inflammation Pharmacology/04. COX-2 Inhibitors.mp415.69MB
  66. 03. Inflammation Pharmacology/05. Disease Modifying Anti Rheumatic Agents (DMARDS).mp444.98MB
  67. 03. Inflammation Pharmacology/06. Gout Medication Colchicine, Uric Acid and More.mp442.54MB
  68. 03. Inflammation Pharmacology/07. Inflammation Pharmacology Questions.mp427.3MB
  69. 04. Endocrine Pharmacology/01.01 Insulin – Diabetes Medications.mp419.07MB
  70. 04. Endocrine Pharmacology/01.02 Insulin Types & Glycemic Excursions – Diabetes Medications.mp425.11MB
  71. 04. Endocrine Pharmacology/01.03 Secretagogues and Biguanides – Diabetes Medications.mp427.98MB
  72. 04. Endocrine Pharmacology/01.04 Metformin, Alpha Glucosidase Inhibitors and Thiazolidinediones – Diabetes Medications.mp440.04MB
  73. 04. Endocrine Pharmacology/01.05 DPP-4 Inhibitors and GLP-1 Analogues – Diabetes Medications.mp428.04MB
  74. 04. Endocrine Pharmacology/01.06 SGLT2 Inhibitors – Diabetes Medications.mp450.16MB
  75. 04. Endocrine Pharmacology/01.07 Questions – Diabetes Medications.mp459.92MB
  76. 04. Endocrine Pharmacology/02.01 Overview – Adrenal Pharmacology.mp44.22MB
  77. 04. Endocrine Pharmacology/02.02 Mineralocorticoids and Glucocorticoids – Adrenal Pharmacology.mp449.8MB
  78. 04. Endocrine Pharmacology/02.03 Catecholamines – Adrenal Pharmacology.mp419.21MB
  79. 04. Endocrine Pharmacology/02.04 Questions and Case Studies – Adrenal Pharmacology.mp422.57MB
  80. 05. CNS - Pharmacology/01.01 Overview of Sedative and Hypnotic Drugs – Sedative Hypnotics.mp451.63MB
  81. 05. CNS - Pharmacology/01.02 Benzodiazepines – Sedative Hypnotics.mp433.35MB
  82. 05. CNS - Pharmacology/01.03 Barbiturates – Sedative Hypnotics.mp412.75MB
  83. 05. CNS - Pharmacology/01.04 Atypical Antipsychotic Drugs – Sedative Hypnotics.mp454.38MB
  84. 05. CNS - Pharmacology/01.05 Questions – Sedative Hypnotics.mp415.52MB
  85. 05. CNS - Pharmacology/01.06 Case Study – Sedative Hypnotics.mp421.39MB
  86. 05. CNS - Pharmacology/02.01 Overview – Antidepressants.mp414.49MB
  87. 05. CNS - Pharmacology/02.02 Monoamine Oxidase Inhibitors (MAOIs) – Antidepressants.mp423.58MB
  88. 05. CNS - Pharmacology/02.03 Tricyclic Antidepressants (TCAs) – Antidepressants.mp423.12MB
  89. 05. CNS - Pharmacology/02.04 Heterocyclic Antidepressants – Antidepressants.mp414.3MB
  90. 05. CNS - Pharmacology/02.05 SNRIs, Serotonin Antagonists and SSRIs – Antidepressants.mp452.57MB
  91. 05. CNS - Pharmacology/02.06 Review – Antidepressants.mp47.24MB
  92. 05. CNS - Pharmacology/02.07 Questions – Antidepressants.mp422.77MB
  93. 05. CNS - Pharmacology/03.01 Overview – Antipsychotics.mp49.09MB
  94. 05. CNS - Pharmacology/03.02 Effects of Increasing Dopamine – Antipsychotics.mp414.06MB
  95. 05. CNS - Pharmacology/03.03 Bipolar Disorder Medication – Antipsychotics.mp431.3MB
  96. 05. CNS - Pharmacology/03.04 Psychotic Disorder Medication – Antipsychotics.mp421.14MB
  97. 05. CNS - Pharmacology/03.05 Clinical Uses of Antipsychotics and Drug Induced Dyskinesia.mp424.68MB
  98. 05. CNS - Pharmacology/03.06 Questions – Antipsychotics.mp415.96MB
  99. 05. CNS - Pharmacology/04.01 Dopamine Hypothesis – Medication of Movement Disorders.mp419.82MB
  100. 05. CNS - Pharmacology/04.02 Dopamine Precursors and Agonists – Treatment of Movement Disorders.mp446.57MB
  101. 05. CNS - Pharmacology/04.03 MAO and COMT Inhibitors – Treatment of Movement Disorders.mp421.99MB
  102. 05. CNS - Pharmacology/04.04 Amantadine and Anticholinergics – Medication of Movement Disorders.mp416.48MB
  103. 05. CNS - Pharmacology/04.05 Postural Tremor, Huntington's Disease, Tourette's Syndrome, Wilsons's Disease and Drug Induced Dyskinesia – Medication of Movement Dis.mp435MB
  104. 05. CNS - Pharmacology/05.01 Overview – Anti-Seizure Medications.mp425.37MB
  105. 05. CNS - Pharmacology/05.02 Treatment Strategies – Anti-Seizure Medications.mp465.55MB
  106. 05. CNS - Pharmacology/05.03 Questions – Anti-Seizure Medications.mp422.01MB
  107. 05. CNS - Pharmacology/06.01 Overview – Anesthetic Drugs.mp44.94MB
  108. 05. CNS - Pharmacology/06.02 Inhaled Anesthetics – Anesthetic Drugs.mp430.42MB
  109. 05. CNS - Pharmacology/06.03 General Anesthetics – Anesthetic Drugs.mp441.59MB
  110. 05. CNS - Pharmacology/06.04 Intravenous Anesthetics – Anesthetic Drugs.mp424.45MB
  111. 05. CNS - Pharmacology/06.05 Case Study – Anesthetic Drugs.mp421.78MB
  112. 05. CNS - Pharmacology/07.01 Overview – Skeletal Muscle Relaxants.mp48.69MB
  113. 05. CNS - Pharmacology/07.02 Neuromuscular Blockers – Skeletal Muscle Relaxants.mp434.55MB
  114. 05. CNS - Pharmacology/07.03 Acute and Chronic Muscle Spasms – Skeletal Muscle Relaxants.mp433.21MB
  115. 05. CNS - Pharmacology/07.04 Questions – Skeletal Muscle Relaxants.mp434.64MB
  116. 05. CNS - Pharmacology/08.01 Overview – Local Anesthetics.mp439.75MB
  117. 05. CNS - Pharmacology/08.02 Esters and Amides – Local Anesthetics.mp432.95MB
  118. 05. CNS - Pharmacology/08.03 Overview – Opioid Analgesics.mp415.11MB
  119. 05. CNS - Pharmacology/08.04 Opioid Agonists – Opioid Analgesics.mp432.95MB
  120. 05. CNS - Pharmacology/08.05 Mixed AgonistsAntagonists and Antagonists – Opioid Analgesics.mp431.52MB
  121. 05. CNS - Pharmacology/08.06 Questions – Local Anesthetics and Opioid Analgesics.mp432.84MB
  122. 06. ANS - Pharmacology/01.01 Autonomic Nervous System (ANS) Overview.mp437.92MB
  123. 06. ANS - Pharmacology/01.02 Dual Innervation.mp423.14MB
  124. 06. ANS - Pharmacology/01.03 Alpha- and Beta-Blockers.mp430.18MB
  125. 06. ANS - Pharmacology/01.04 Sympathetic Blockers.mp428.71MB
  126. 06. ANS - Pharmacology/02.01 Cholinomimetic Activators.mp419.25MB
  127. 06. ANS - Pharmacology/02.02 Cholinomimetic Effects.mp437.52MB
  128. 06. ANS - Pharmacology/02.03 Special Topic Cholinergic Toxicity, Poisoning, Myestenia Crisis and Cholinergic Crisis.mp436.87MB
  129. 06. ANS - Pharmacology/03.01 Sympathomimetic Activators.mp430.33MB
  130. 06. ANS - Pharmacology/03.02 Sympathomimetic Effects.mp479.06MB
  131. 06. ANS - Pharmacology/03.03 Global Effect of Sympathomimetic Drugs on the Vascular System.mp437.12MB
  132. 06. ANS - Pharmacology/03.04 Anticholinergic Drugs.mp457.09MB
  133. 07. Respiratory Pharmacology/01. Asthma Medications.mp414.35MB
  134. 07. Respiratory Pharmacology/02. Bronchodilators.mp421.59MB
  135. 07. Respiratory Pharmacology/03. Corticosteroids.mp414.4MB
  136. 07. Respiratory Pharmacology/04. Leukotriene Receptor Antagonists.mp411.4MB
  137. 07. Respiratory Pharmacology/05. Anti-Inflammatory Agents Release Inhibitors and IgE-Antibodies.mp412.96MB
  138. 07. Respiratory Pharmacology/06. Asthma Medication Questions.mp416.18MB
  139. 08. Pharmacology of Blood Coagulation/01. Overview Coagulant Drugs.mp45.71MB
  140. 08. Pharmacology of Blood Coagulation/02. Antiplatelets.mp444.48MB
  141. 08. Pharmacology of Blood Coagulation/03. Anticoagulants.mp469.01MB
  142. 08. Pharmacology of Blood Coagulation/04. Thrombolytics and Procoagulants.mp439.01MB
  143. 08. Pharmacology of Blood Coagulation/05. Questions Coagulant Drugs.mp421.55MB
  144. 09. Gastrointestinal Pharmacology/01. Questions and Case Studies Steroids, Cyclosprine and Crohn's Disease.mp445.75MB
  145. 09. Gastrointestinal Pharmacology/02 Inflammatory Bowel Disease Medication.mp476.62MB
  146. 09. Gastrointestinal Pharmacology/03. Stomach Ulcer (Peptic Acid Disease) Medication.mp451.2MB
  147. 09. Gastrointestinal Pharmacology/04. Motility Disorder Medication.mp453.93MB
  148. 09. Gastrointestinal Pharmacology/05. Nausea Medication Antiemetics – Gastrointestinal Drugs.mp440.63MB
  149. 09. Gastrointestinal Pharmacology/06. Pancreatic Enzyme Replacement Therapy (PERT) and Gallstone Prevention – Gastrointestinal Drugs.mp416.88MB
  150. 09. Gastrointestinal Pharmacology/07. Irritable Bowel Syndrome (IBS) Medication.mp416.89MB
  151. 09. Gastrointestinal Pharmacology/08. Questions and Case Studies H2 Blockers, GERD Medication and Domperidone.mp418.88MB
  152. 10. Toxicology/03.05 Toxicology Questions & Case Studies.mp455.24MB
  153. 11. Cardiovascular Pharmacology/01.01 Introduction to High Blood Pressure Medication – Drugs in Hypertension.mp49.76MB
  154. 11. Cardiovascular Pharmacology/01.02 Diuretics – Drugs in Hypertension.mp456.44MB
  155. 11. Cardiovascular Pharmacology/01.03 Renin Angiotensin Aldosterone – Drugs in Hypertension.mp458.57MB
  156. 11. Cardiovascular Pharmacology/01.04 Vasodilators – Drugs in Hypertension.mp448.1MB
  157. 11. Cardiovascular Pharmacology/01.05 Alpha Blockers – Drugs in Hypertension.mp411.74MB
  158. 11. Cardiovascular Pharmacology/01.06 Beta Blockers – Drugs in Hypertension.mp429.15MB
  159. 11. Cardiovascular Pharmacology/01.07 Postganglionic Sympathetic Nerve Terminal Blockers and Monoamine Oxidase Inhibitors – Drugs in Hypertension.mp413.39MB
  160. 11. Cardiovascular Pharmacology/01.08 Lines of Therapy – Drugs in Hypertension.mp447.59MB
  161. 11. Cardiovascular Pharmacology/01.09 Pulmonary Hypertension Medication – Drugs in Hypertension.mp416.51MB
  162. 11. Cardiovascular Pharmacology/01.10 Questions and Case Studies – Drugs in Hypertension.mp433.77MB
  163. 11. Cardiovascular Pharmacology/02.01 Introduction – Angina and Heart Failure Management.mp415.62MB
  164. 11. Cardiovascular Pharmacology/02.02 Nitrates – Angina and Heart Failure Management.mp428.34MB
  165. 11. Cardiovascular Pharmacology/02.03 Cardiac Depressants, Metabolic Modifiers and Slow Sodium Channel Inhibitors – Angina and Heart Failure Management.mp421.11MB
  166. 11. Cardiovascular Pharmacology/02.04 Inotropes – Angina and Heart Failure Management.mp437.25MB
  167. 11. Cardiovascular Pharmacology/02.05 Vasodilators – Angina and Heart Failure Management.mp418.01MB
  168. 11. Cardiovascular Pharmacology/02.06 Renin-Angiotensin Agents and Beta Blockers – Angina and Heart Failure Management.mp415.14MB
  169. 11. Cardiovascular Pharmacology/02.07 Questions – Angina and Heart Failure Management.mp439.23MB
  170. 11. Cardiovascular Pharmacology/03.01 Introduction – Antiarrhythmic Drugs.mp44.45MB
  171. 11. Cardiovascular Pharmacology/03.02 Group 1 Sodium Channel Blockers – Antiarrhythmic Drugs.mp432.74MB
  172. 11. Cardiovascular Pharmacology/03.03 Group 2 Beta Blockers – Antiarrhythmic Drugs.mp411.81MB
  173. 11. Cardiovascular Pharmacology/03.04 Group 3 Potassium Channel Blockers – Antiarrhythmic Drugs.mp423.91MB
  174. 11. Cardiovascular Pharmacology/03.05 Group 4 Calcium Channel Blockers – Antiarrhythmic Drugs.mp412.02MB
  175. 11. Cardiovascular Pharmacology/03.06 Group 5 Other Antiarrhythmics – Antiarrhythmic Drugs.mp424.87MB
  176. 11. Cardiovascular Pharmacology/03.07 Questions – Antiarrhythmic Drugs.mp421.42MB
  177. 11. Cardiovascular Pharmacology/04.01 Introduction Bile Acid Sequestrants, Niacin and Fibrates – Lipid Control.mp440.71MB
  178. 11. Cardiovascular Pharmacology/04.02 HMG-CoA Reductase Inhibitors – Lipid Control.mp463.37MB
  179. 11. Cardiovascular Pharmacology/04.03 Fat Absorption and MTP Inhibitors – Lipid Control.mp424.28MB
  180. 11. Cardiovascular Pharmacology/04.04 PCSK9 Inhibitors – Lipid Control.mp455.59MB
  181. 11. Cardiovascular Pharmacology/04.05 Questions – Lipid Control.mp418.96MB
  182. 12. Reproductive Pharmacology/01. Overview – Reproductive Pharmacology.mp410.31MB
  183. 12. Reproductive Pharmacology/02. Estrogens and Progestins – Reproductive Pharmacology.mp466.52MB
  184. 12. Reproductive Pharmacology/03. Anti-Estrogens and Antiprogestins – Reproductive Pharmacology.mp441.68MB
  185. 12. Reproductive Pharmacology/04. Androgens and Antiandrogens.mp440.67MB
  186. 12. Reproductive Pharmacology/05. Questions and Case Studies – Reproductive Pharmacology.mp420.81MB
友情提示
不会用的朋友看这里 把磁力链接复制到离线下载，或者bt下载软件里即可下载文件，或者直接复制迅雷链接到迅雷里下载！ 亲，你造吗？将网页分享给您的基友，下载的人越多速度越快哦！

违规内容投诉邮箱：[email protected]

概述 838888磁力搜索是一个磁力链接搜索引擎，是学术研究的副产品，用于解决资源过度分散的问题 它通过BitTorrent协议加入DHT网络，实时的自动采集数据，仅存储文件的标题、大小、文件列表、文件标识符（磁力链接）等基础信息 838888磁力搜索不下载任何真实资源，无法判断资源的合法性及真实性，使用838888磁力搜索服务的用户需自行鉴别内容的真伪 838888磁力搜索不上传任何资源，不提供Tracker服务，不提供种子文件的下载，这意味着838888磁力搜索 838888磁力搜索是一个完全合法的系统
838888磁力链接 磁力链接bt种子搜索引擎磁力搜索 DMCA